company background image
SRT3 logo

Sartorius XTRA:SRT3 Stock Report

Last Price

€253.00

Market Cap

€15.7b

7D

-5.8%

1Y

-20.3%

Updated

26 May, 2024

Data

Company Financials +

Sartorius Aktiengesellschaft

XTRA:SRT3 Stock Report

Market Cap: €15.7b

Sartorius Aktiengesellschaft Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sartorius
Historical stock prices
Current Share Price€253.00
52 Week High€383.70
52 Week Low€215.30
Beta0.89
1 Month Change-12.82%
3 Month Change-24.97%
1 Year Change-20.26%
3 Year Change-37.76%
5 Year Change48.82%
Change since IPO426.81%

Recent News & Updates

Recent updates

Shareholder Returns

SRT3DE Life SciencesDE Market
7D-5.8%-2.5%-0.5%
1Y-20.3%-13.1%5.2%

Return vs Industry: SRT3 underperformed the German Life Sciences industry which returned -13.1% over the past year.

Return vs Market: SRT3 underperformed the German Market which returned 5.2% over the past year.

Price Volatility

Is SRT3's price volatile compared to industry and market?
SRT3 volatility
SRT3 Average Weekly Movement6.6%
Life Sciences Industry Average Movement5.9%
Market Average Movement4.9%
10% most volatile stocks in DE Market10.7%
10% least volatile stocks in DE Market2.5%

Stable Share Price: SRT3's share price has been volatile over the past 3 months.

Volatility Over Time: SRT3's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
187014,614Joachim Kreuzburgwww.sartorius.com

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products.

Sartorius Aktiengesellschaft Fundamentals Summary

How do Sartorius's earnings and revenue compare to its market cap?
SRT3 fundamental statistics
Market cap€15.68b
Earnings (TTM)€148.80m
Revenue (TTM)€3.31b

117.4x

P/E Ratio

5.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SRT3 income statement (TTM)
Revenue€3.31b
Cost of Revenue€1.80b
Gross Profit€1.51b
Other Expenses€1.36b
Earnings€148.80m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 19, 2024

Earnings per share (EPS)2.16
Gross Margin45.55%
Net Profit Margin4.49%
Debt/Equity Ratio134.4%

How did SRT3 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

25%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.